France’s Laclarée bags €3.5M in Seed funding
Summary
Villeurbanne-based Laclar\xe9e, a French company developing adaptive eyeglasses for presbyopia correction, has secured 3.5M in equity Seed round funding.The investment came from vision-care investor Rimonci Capital, along with existing investors UI-Investissement, High-Tech Gr\xfcnderFonds (HTGF), and business angels.Richel LIU, founder and manager of Rimonci Capital, says, We are thrilled to support Laclar\xe9e in bringing its breakthrough technology to new markets, setting a new standard for presbyopia correction worldwide. This investment aligns with Rimoncis mission to back transformative technologies in vision care that address unmet medical needs for better vision and insight.This funding, along with a 2.5M grant from the EIC Accelerator, brings the French companys total financing to 6M.The proceeds will support the development of Laclar\xe9es first commercial product, expected by mid-2026.Bruno Berge, CEO and founder of Laclar\xe9e, says, We are happy that Rimonci joins our current investors UI-Investissement and HTGF, confirming our global approach to the market.In the past years, the Laclar\xe9e team has worked hard to seek the wearers feedback and expectations, and the result has turned positive: many presbyopes want to wear Laclar\xe9e eyeglasses as their visual correction mean.This Seed round will be key for Laclar\xe9e to offer these customers the first commercial autofocussing eyeglass pair.Founded in 2016 by physicist and entrepreneur Bruno Berge, Laclar\xe9e brings together expertise in optics, electronics, materials, and microfluidics.The company is developing a technology that mimics the eyes natural ability to autofocus, offering a new approach to correcting presbyopiaa condition that affects 2 billion people worldwide after age 45.Presbyopia makes it difficult to focus on close objects, impacting daily activities like reading or using digital devices. Current solutions, including progressive lenses, come with limitations and can cause discomfort, such as visual fatigue, headaches, and posture-related issues.Laclar\xe9e is developing autofocusing eyeglasses for presbyopia using its patented opto-fluidic technology. These eyeglasses feature variable focus lenses, actuating units in the temples, and distance sensors, allowing real-time adaptation to the users viewing distance.The companys lenses also incorporate corrections for hyperopia, astigmatism, and myopia based on the users prescription.Laclar\xe9e claims to have conducted extensive wearer tests, demonstrating the benefits of its autofocusing eyeglasses and their ability to restore natural focusing. HTGF operates as a public-private partnership, backed by the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital, and 45 companies and family offices.
Funding
Review available funding amount, funding date, investors, and linked company information related to France’s Laclarée bags €3.5M in Seed funding in the interactive ISVWorld profile.